Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;40(7):1067-1073.
doi: 10.1007/s10571-020-00799-1. Epub 2020 Jan 28.

The Inhibition of Inflammatory Signaling Pathway by Secretory Leukocyte Protease Inhibitor can Improve Spinal Cord Injury

Affiliations
Review

The Inhibition of Inflammatory Signaling Pathway by Secretory Leukocyte Protease Inhibitor can Improve Spinal Cord Injury

Renzhe Tang et al. Cell Mol Neurobiol. 2020 Oct.

Abstract

Spinal cord injury leads to loss of sensory motor functions below the damaged area, and can significantly affects physical and mental health. An effective spinal cord injury treatment is currently unavailable, in part, because of the intricacy of the brain, as well as the complex pathophysiological mechanism of the injury. Inflammation is an important biological process in multitudinous diseases, with no exception for spinal cord injury. Nuclear factor kappa beta (NF-κB) signaling pathway is a key inflammatory element, as it is involved in cell survival, apoptosis, proliferation, differentiation, and immune response. Activation of the NF-κB signaling pathway leads to the release of a large number of inflammatory factors that can affect tissue repair. Hence, the inhibition of inflammatory responses could improve the repair of injured spinal cord tissues. Secretory leukocyte protease inhibitor (SLPI) has anti-inflammatory and anti-bacterial properties, and promotes wound healing. SLPI can bind to the promoter region of tumor necrosis factor-αand interleukin-8 (IL-8) to inhibit the NF-κB signaling pathway. Additionally, SLPI can reduce secondary damages after spinal cord injury, and prevent further complications. In this report, we analyze the pathophysiological mechanism of spinal cord injury, the role of NF-κB signaling pathway following spinal cord injury, and how SLPI regulates the NF-κB signaling pathway to curtail inflammatory reaction.

Keywords: Ecretory leukocyte protease inhibitor; Inflammation; Nuclear factor kappa beta signaling pathway; Oxidative stress; Spinal cord injury.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Fig. 1
Fig. 1
Role of SLPI in SCI. In the wake of SCI, SLPI directly suppresses the NF-κB signaling pathway, thus, exhibiting its anti-inflammatory effects. Sect. “SLPI reduces inflammatory reaction via inhibition of NF-κB signaling pathway (Fig. 1)” of the manuscript has the comprehensive elocution of this mechanism. “⊥” for inhibition and “ → ” for activation

Similar articles

Cited by

References

    1. Allison DJ, Ditor DS (2015) Immune dysfunction and chronic inflammation following spinal cord injury. Spinal Cord 53:14–18 - PubMed
    1. Ambrosi N, Caro F, Guerrieri D et al (2018) SLPI expression on kidney biopsies correlates with better clinical outcomes. Transplantation 102:S326–S327
    1. Anwar MA, Al Shehabi TS, Eid AH (2016) Inflammogenesis of secondary spinal cord injury. Front Cell Neurosci 10:98 - PMC - PubMed
    1. Boato F, Rosenberger K, Nelissen S et al (2013) Absence of IL-1beta positively affects neurological outcome, lesion development and axonal plasticity after spinal cord injury. J Neuroinflamm 10:6 - PMC - PubMed
    1. Boyce BF, Xiu Y, Li J et al (2015) NF-kappaB-mediated regulation of osteoclastogenesis. Endocrinol Metab (Seoul) 30:35–44 - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources